DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02256 ABBISKO-B

Closed Add to Porfolio
Index Constituent : None
Major Shareholders XU Yao-Chang & Associates (11.10%)
Qiming Corporate GP VI, Ltd. (5.74%)
Shi Yi (5.71%)
Futu Trustee Limited (5.70%)
Allianz SE (5.68%)
GIC Private Limited (5.30%)		 Sector Health Care & Biotechnology
Web Site http://www.abbisko.com Tel (86 21) 6891-2098
Email IR@abbisko.com Fax N/A
Related Equities N/A
Principal Activities The Company’s subsidiaries are involved in the research and development of pharmaceutical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top